Healthcare

Pharma-Biotech Alliance ManagementCritical Success Factors

 

INDUSTRY
Healthcare

RELEASE DATE
30-May-2006
REGION
Europe
DELIVERABLE TYPE
Market Research

RESEARCH CODE
B937-01-00-00-00
SKU
HC01182-EU-MR_05314
Yes
SHARE

Pharma-Biotech Alliance ManagementCritical Success Factors
Published on: 30-May-2006 | SKU: HC01182-EU-MR_05314

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

This research service provides an overview of the pharma-biotech industry in terms of critical success factors and alliance management.

Overview

  • Summary of Pharma-Biotech Alliance Management - Critical Success Factors

Exchange Rates

  • Currency Exchange Rates

Scope and Methodology

  • Research Methodology

Introduction

  • Background
  • Segmentation

Overview

  • Overview of the Pharmaceutical Industry
  • Identification of the Challenges Facing Pharmaceutical Companies

Overview

  • Overview of the Biotechnology Industry
  • Identification of the Challenges Facing Biotechnology Companies

Challenges

  • Challenges

Market Drivers

  • Market Drivers

Alliances

  • Introduction
  • Overview and Key Trends
  • Key Pharma-Biotech Alliances
  • Case Study - Novartis

Alliances

  • Introduction
  • Overview and Key Trends
  • Key Biotech-Biotech Alliances
  • Case Study - Serono

Success Factors

  • Success Factors

Recommendations

  • Recommendations
  • Emerging / Small Biotech Companies
  • Larger Biotech / Biopharmaceutical Companies
  • Large Pharma Companies
  • Summary

Frost & Sullivan Awards for the European Pharma and Biotech Industry

  • 2006 Frost & Sullivan Awards
  • Entrepreneurial Company Award
  • Technology Innovation Award
  • Competitive Strategy Leadership Award

Industry Participants

  • Major Participants

Biotech

  • Number of Biotech Companies
  • Number of Employees in Biotech Companies
  • EPO Biotech Patent
  • Government R&D Investment in Biotechnology
  • Percent Government Biotech R & D Investment
  • Private Investment in Biotechnology
  • Per cent Private Investment in Biotechnology

Pharmaceutical R&D

  • Pharmaceutical R&D Expenditure
  • Percent Pharmaceutical R&D Expenditure

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

16 Oct 2026   |   Global   |   Market Research

Public Sector Healthcare Cloud Market, North America and Europe, 2026

Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...

16 Oct 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...

15 Oct 2026   |   Global   |   Frost Radar

Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026

The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...

08 Oct 2026   |   Global   |   Frost Radar

Frost Radar: Endoscopy Device Technology Ecosystem, 2026

The endoscopy device market is advancing toward higher-quality visualization and improved clinical decision-making, with innovation across 4K ultrahigh-definition display systems, image-enhanced endoscopy, and computer-aided detection systems. Advanced visualization is evolving through improvements ...

07 Oct 2026   |   Global   |   Technology Research

Growth Opportunities in Image-Guided Cancer Ablation Systems

Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasin...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This research service provides an overview of the pharma-biotech industry in terms of critical success factors and alliance management.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Industries Healthcare
WIP Number B937-01-00-00-00
Is Prebook No

Pharma-Biotech Alliance ManagementCritical Success Factors

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01182-EU-MR_05314